Abstract
Asbestos has been known for many years to cause a range of both non-malignant and malignant diseases. Over fifty countries have totally banned the use of asbestos, but in emerging economies there continues to be considerable use of asbestos. Unfortunately, the United States is one of the very few developed countries that has not banned the use of this material due to industry intransigence. With the continued use of asbestos because of the lack of a worldwide ban there can be expected to be disease well into the future, for at least fifty more years, due to the long latency period for disease development. Stopping the use of asbestos has been shown to decrease the incidence, as seen in Sweden, of disease and is clearly the recommended path forward.
Keywords: Asbestos, chrysotile, amphibole, international ban, cancer, fibrosis.
Current Respiratory Medicine Reviews
Title:Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban
Volume: 12 Issue: 1
Author(s): Arthur L. Frank
Affiliation:
Keywords: Asbestos, chrysotile, amphibole, international ban, cancer, fibrosis.
Abstract: Asbestos has been known for many years to cause a range of both non-malignant and malignant diseases. Over fifty countries have totally banned the use of asbestos, but in emerging economies there continues to be considerable use of asbestos. Unfortunately, the United States is one of the very few developed countries that has not banned the use of this material due to industry intransigence. With the continued use of asbestos because of the lack of a worldwide ban there can be expected to be disease well into the future, for at least fifty more years, due to the long latency period for disease development. Stopping the use of asbestos has been shown to decrease the incidence, as seen in Sweden, of disease and is clearly the recommended path forward.
Export Options
About this article
Cite this article as:
Frank L. Arthur, Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban, Current Respiratory Medicine Reviews 2016; 12 (1) . https://dx.doi.org/10.2174/1573398X11666151026222515
DOI https://dx.doi.org/10.2174/1573398X11666151026222515 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CD147 Promotes Melanoma Progression Through Hypoxia-Induced MMP2 Activation
Current Molecular Medicine Oncolytic Viruses: Programmable Tumour Hunters
Current Gene Therapy Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy
Current Cancer Therapy Reviews Recent Advances in Oncological Submissions of Dendrimer
Current Pharmaceutical Design KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker
Combinatorial Chemistry & High Throughput Screening Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy
Current Molecular Pharmacology The Potential for Targeting Oncogenic WNT/β -Catenin Signaling in Therapy
Current Drug Targets Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups
Current Topics in Medicinal Chemistry Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
Current Cancer Drug Targets Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis
Current Medicinal Chemistry Carbon Nanotubes in the Treatment of Skin Cancers: Safety and Toxic ological Aspects
Pharmaceutical Nanotechnology The Extracellular Matrix Regulates Cancer Progression and Therapy Response: Implications for Prognosis and Treatment
Current Pharmaceutical Design The Chlorophyll Catabolite Pheophorbide a as a Photosensitizer for the Photodynamic Therapy
Current Medicinal Chemistry Targeting Mitochondria in Fighting Cancer
Current Pharmaceutical Design Analysis of Hypoxiamir-Gene Regulatory Network Identifies Critical MiRNAs Influencing Cell-Cycle Regulation Under Hypoxic Conditions
MicroRNA Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
Current Pharmaceutical Design Editorial: The Real Impact of Target Therapy in Cancer Patients: Between Hope and Reality
Current Cancer Drug Targets Eph/Ephrin Signalling and Function in Oncogenesis: Lessons from Embryonic Development
Current Cancer Drug Targets The Potential and Rationale for COX-2 Inhibitors in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier
Current Drug Metabolism